• Current

homepage |
SillaJen, Inc. is a privately-held biotechnology company focused on engineering and developing best-in-class oncolytic virus immunotherapeutics, with its most advanced product in Phase 3 clinical trials for liver cancer. SillaJen’s US affiliate, SillaJen Biotherapeutics, Inc., manages Clinical Operations, R&D, regulatory affairs and manufacturing capabilities. SillaJen Biotherapeutics is located in San Francisco, California.

homepage |
WCCT Global is a multi-site, full service pharmaceutical contract research organization (CRO) of outsourced early drug development and late phase CRO services to the pharmaceutical, biotechnology and medical device industries. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Renal, and Vaccines.

맨처음이전 1 다음맨뒤로